Phreesia, a life sciences and healthcare software as a service firm, is acquiring MediFind, a data science health tech company, to facilitate faster matchmaking between patients and a variety of services.
Phreesia, which sells applications to automate and manage patient intake, will integrate MediFind’s machine learning and AI tech to help connect patients with leading experts, trials, health systems and healthcare technologies through what it calls “advanced analytics.”
The idea is to combine the two specialties of the companies into one and match patients to their healthcare services quicker than before, especially those with serious, chronic and rare diseases.
Financial details of the deal were not disclosed.
“I’m incredibly proud that our platform can help sift through the noise and identify doctors at the forefront of their fields,” said MediFind CEO Patrick Howie in a release. He founded the company after his brother was diagnosed with a rare cancer.
Howie, who now moves into a VP of product management at Phreesia, added: “With Phreesia’s size, scale and experience, we’re now going to be able to reach many more people, which is very exciting.”
“At Phreesia, we’re always thinking about how to arm patients with the right tools and relevant information, whether that’s a message at the point of care to speed a rare-disease diagnosis, a reminder to schedule overdue preventive screening, or educational content about vaccine safety and effectiveness,” said David Linetsky, an SVP at Phreesia.